Cognito Therapeutics Revenue, Growth & Competitor Profile

DBA COGNITO THERRAPEUTICS, INC.

Company Profile & Annual Report for Cognito Therapeutics

Access the complete profile.

Cognito Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	1218 Massachusetts Ave Suite 200 Cambridge, MA 02138

Note: Revenues for privately held companies are statistical evaluations.


Cognito Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cognito Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Cognito Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Cognito Therapeutics Annual Revenue and Growth Rate

Cognito Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cognito Therapeutics's revenues are gauged from an analysis of company filings.

Cognito Therapeutics's Income Statement (based on Industry Averages)

Cognito Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Cognito Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
November 15, 2023	13	86%	$126 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Cognito Therapeutics is developing and marketing. Cognito Therapeutics doesn't have any recent trademark applications, indicating Cognito Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SPECTRIS Medical devices, namely, headsets and wearable devices for the delivery of visual, audio and tactile sensory stimulation for the diagnosis, prevention and treatment of neurodegenerative and neurological disorders and diseases; medical devices, namely, headsets for the delivery of non-invasive neuromodulation for the treatment of neurodegenerative and neurological disorders and disease	12/20/2023

See all trademarks and details in the Full Report.

Market Share of Cognito Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cognito Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Cognito Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Future Competition: Cognito Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Cognito Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)